LAB Act Passage a Critical Step Forward for Diagnostic Sector of Medtech Industry | AdvaMed

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the broader government funding agreement expected to be signed into law this week by President Trump:

Read the full article here

Related Articles